Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Antitubercular Agents | 4 | 2017 | 775 | 1.17 | Why? |
| Tuberculosis, Multidrug-Resistant | 2 | 2017 | 433 | 0.93 | Why? |
| Isosporiasis | 1 | 2018 | 3 | 0.75 | Why? |
| Isospora | 1 | 2018 | 5 | 0.75 | Why? |
| Receptors, Interleukin-12 | 1 | 2017 | 14 | 0.73 | Why? |
| Thymoma | 1 | 2018 | 47 | 0.69 | Why? |
| Mycobacterium Infections | 1 | 2017 | 72 | 0.69 | Why? |
| Lymphadenitis | 1 | 2017 | 53 | 0.65 | Why? |
| Receptors, Pattern Recognition | 1 | 2017 | 128 | 0.62 | Why? |
| Mycobacterium bovis | 1 | 2017 | 125 | 0.60 | Why? |
| Agammaglobulinemia | 1 | 2018 | 213 | 0.58 | Why? |
| Cystic Fibrosis | 3 | 2019 | 1104 | 0.57 | Why? |
| Bronchiectasis | 1 | 2018 | 312 | 0.51 | Why? |
| Pyrazines | 2 | 2021 | 1783 | 0.49 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2017 | 368 | 0.49 | Why? |
| Amides | 2 | 2021 | 1864 | 0.48 | Why? |
| Immune System Diseases | 1 | 2017 | 410 | 0.47 | Why? |
| Sinusitis | 1 | 2019 | 649 | 0.45 | Why? |
| Mycobacterium tuberculosis | 2 | 2017 | 1164 | 0.45 | Why? |
| Tuberculosis | 3 | 2017 | 2895 | 0.32 | Why? |
| BCG Vaccine | 1 | 2017 | 1137 | 0.31 | Why? |
| Child Nutrition Disorders | 1 | 2007 | 86 | 0.31 | Why? |
| Immunoglobulins, Intravenous | 1 | 2018 | 2705 | 0.30 | Why? |
| Rifampin | 2 | 2017 | 276 | 0.29 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.24 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.24 | Why? |
| Iran | 5 | 2019 | 5467 | 0.21 | Why? |
| Scedosporium | 1 | 2019 | 9 | 0.20 | Why? |
| Zinc | 1 | 2007 | 817 | 0.20 | Why? |
| Antiviral Agents | 3 | 2020 | 41703 | 0.19 | Why? |
| Aspergillosis, Allergic Bronchopulmonary | 1 | 2019 | 38 | 0.19 | Why? |
| Fimbriae, Bacterial | 1 | 2017 | 14 | 0.18 | Why? |
| Paecilomyces | 1 | 2017 | 9 | 0.18 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.18 | Why? |
| Lung Diseases, Fungal | 1 | 2019 | 167 | 0.17 | Why? |
| Voriconazole | 1 | 2019 | 206 | 0.17 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.17 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.17 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.17 | Why? |
| HIV Protease Inhibitors | 1 | 2020 | 434 | 0.16 | Why? |
| Granulomatous Disease, Chronic | 1 | 2017 | 60 | 0.16 | Why? |
| Parvovirus B19, Human | 1 | 2017 | 73 | 0.16 | Why? |
| Isoniazid | 1 | 2017 | 105 | 0.16 | Why? |
| Tuberculosis, Pulmonary | 1 | 2007 | 1171 | 0.16 | Why? |
| Granuloma | 1 | 2017 | 88 | 0.16 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.16 | Why? |
| Sarcoidosis, Pulmonary | 1 | 2017 | 91 | 0.16 | Why? |
| Pleura | 1 | 2017 | 178 | 0.15 | Why? |
| Mycobacterium | 1 | 2017 | 143 | 0.15 | Why? |
| Aspergillus | 1 | 2019 | 347 | 0.15 | Why? |
| Delayed-Action Preparations | 1 | 2017 | 291 | 0.14 | Why? |
| Parvoviridae Infections | 1 | 2017 | 222 | 0.14 | Why? |
| Interferon-beta | 1 | 2020 | 979 | 0.14 | Why? |
| Genome, Bacterial | 1 | 2017 | 446 | 0.13 | Why? |
| Lymphocyte Subsets | 1 | 2021 | 987 | 0.13 | Why? |
| Child, Preschool | 5 | 2019 | 36283 | 0.12 | Why? |
| Flow Cytometry | 1 | 2021 | 2393 | 0.12 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.12 | Why? |
| Microbial Sensitivity Tests | 2 | 2019 | 2886 | 0.11 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.11 | Why? |
| Antifungal Agents | 2 | 2019 | 1828 | 0.11 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.11 | Why? |
| Nanotechnology | 1 | 2017 | 821 | 0.10 | Why? |
| Mycoses | 1 | 2017 | 589 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.10 | Why? |
| Infant | 4 | 2019 | 30274 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.09 | Why? |
| Child | 6 | 2019 | 70012 | 0.09 | Why? |
| Directly Observed Therapy | 1 | 2007 | 34 | 0.09 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.09 | Why? |
| Humans | 19 | 2021 | 930598 | 0.09 | Why? |
| Female | 13 | 2021 | 380317 | 0.09 | Why? |
| Male | 13 | 2021 | 367725 | 0.08 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.08 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.07 | Why? |
| Statistics, Nonparametric | 1 | 2007 | 1008 | 0.07 | Why? |
| Blood Proteins | 1 | 2007 | 551 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.06 | Why? |
| Serum Albumin | 1 | 2007 | 571 | 0.06 | Why? |
| Nutrition Assessment | 1 | 2007 | 527 | 0.06 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Adult | 8 | 2021 | 244371 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.05 | Why? |
| Prevalence | 3 | 2019 | 25773 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.05 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.05 | Why? |
| DNA, Ribosomal Spacer | 1 | 2019 | 49 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.05 | Why? |
| Renal Dialysis | 1 | 2017 | 4358 | 0.05 | Why? |
| Tubulin | 1 | 2019 | 67 | 0.05 | Why? |
| DNA, Fungal | 1 | 2019 | 95 | 0.05 | Why? |
| Drug Monitoring | 1 | 2007 | 1408 | 0.05 | Why? |
| Animals | 2 | 2020 | 78931 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.04 | Why? |
| Lecithins | 1 | 2017 | 5 | 0.04 | Why? |
| Itraconazole | 1 | 2019 | 135 | 0.04 | Why? |
| Nutritional Status | 1 | 2007 | 1403 | 0.04 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 198 | 0.04 | Why? |
| Microbiological Techniques | 1 | 2019 | 232 | 0.04 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.04 | Why? |
| Solubility | 1 | 2017 | 382 | 0.04 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.04 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.04 | Why? |
| Microscopy | 1 | 2019 | 414 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Chitosan | 1 | 2017 | 196 | 0.03 | Why? |
| Tomography, X-Ray Computed | 2 | 2019 | 25144 | 0.03 | Why? |
| Th2 Cells | 1 | 2017 | 680 | 0.03 | Why? |
| Receptors, Cell Surface | 1 | 2017 | 586 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Antigens, CD | 1 | 2017 | 984 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.03 | Why? |
| Particle Size | 1 | 2017 | 1052 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Lung | 2 | 2017 | 31049 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.03 | Why? |
| Drug Carriers | 1 | 2017 | 590 | 0.03 | Why? |
| Peritoneal Dialysis | 1 | 2017 | 498 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Sputum | 1 | 2019 | 1720 | 0.03 | Why? |
| Cluster Analysis | 1 | 2019 | 3001 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.03 | Why? |
| Sequence Analysis, DNA | 1 | 2019 | 2830 | 0.03 | Why? |
| Aged | 3 | 2021 | 215776 | 0.02 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.02 | Why? |
| Anemia | 1 | 2017 | 789 | 0.02 | Why? |
| Viremia | 1 | 2017 | 1020 | 0.02 | Why? |
| Phylogeny | 2 | 2019 | 13341 | 0.02 | Why? |
| Thorax | 1 | 2019 | 1873 | 0.02 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.02 | Why? |
| Kinetics | 1 | 2017 | 3238 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.02 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Time Factors | 1 | 2007 | 31397 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2017 | 9091 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.01 | Why? |
| Prospective Studies | 1 | 2019 | 43301 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2017 | 51949 | 0.00 | Why? |
Velayati's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(94)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_